🔎 Trials Near Me

Home › Liver Cancer › California › San Francisco

Liver Cancer clinical trials in San Francisco, CA

6 studies for Liver Cancer are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Distance-Based Exercise to Preserve Function and Prevent Disability

Recruiting
  • Kaiser Permanente-San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884

National Liver Cancer Screening Trial

RecruitingPhase 4
  • University of California, San Francisco, San Francisco
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

RecruitingObservational study
  • Sutter Bay Hospitals, San Francisco
Ages 22 and older · All sexes · Updated Sep 11, 2026 · NCT06486454

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

RecruitingPhase 1/2
  • UCSF Benioff Children's Hospitals, San Francisco
Ages 1 to 21 · All sexes · Updated Jul 6, 2026 · NCT04634357

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

RecruitingPhase 2
  • University of California San Francisco, San Francisco
Ages 0 to 30 · All sexes · Updated Feb 24, 2026 · NCT04134559

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, San Francisco
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

About Liver Cancer

The most common form of liver cancer in adults is hepatocellular carcinoma. Learn about diagnosis, treatment and taking part in research studies.

More about Liver Cancer on MedlinePlus

Liver Cancer trials in other cities

Other studies in San Francisco

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.